BAM-15 is a novel mitochondrial uncoupler designed for targeted metabolic interventions. It functions as a protonophore, fostering controlled mitochondrial uncoupling to enhance energy expenditure while minimizing toxicity. Preclinical studies reveal its potential applications in metabolic disorders and environmental pest control, particularly against invasive aquatic species. Safety evaluations indicate a favorable therapeutic window, although further toxicological assessments are necessary.
oral, intraperitoneal, topical
0.1-10 mg/kg (animal studies)
2-6 hours (estimated)
stable under dry conditions, light sensitive
mitochondrial respiratory complexes, ATP synthase
BAM-15 represents a novel class of mitochondrial uncouplers developed through rational drug design to overcome the limitations of classical uncoupling agents . Unlike traditional compounds such as 2,4-dinitrophenol, BAM-15 was engineered to provide controlled mitochondrial uncoupling with reduced systemic toxicity .
mitochondrial respiratory complexes
ATP synthase
Research Use Only (RUO) - BAM-15 Peptide: Mitochondrial Uncoupler Research Insights is currently available for research purposes only and is not approved by regulatory agencies for human therapeutic use.
This report is generated for educational and informational purposes only. All research content is compiled from credible, peer-reviewed, and verified external scientific sources. This material does not constitute medical advice, diagnosis, or treatment recommendations. Always consult a qualified healthcare professional before making any decisions related to your health or treatment.